Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Implications of Facebook's Page Commenting Changes

  • Broadcast in Business
Pharmaguy

Pharmaguy

Featured Host
×  

Follow This Show

If you liked this show, you should follow Pharmaguy.
h:755
s:1772005
archived
Play

Interview of Matt Snodgrass, Social Media Director at WCG, about Facebook's planned changes to its "whitelisting" policy and its implications for pharmaceutical marketers.

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled